Search research articles
Contact Us
Filters
Showing results (311-320 of 324) with videos related to
Page
of 33
Sort By:
ESMO Open
|
November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI
F Martin-Moro, L Bento, J Marquet, et al.
Journal of Medicinal Chemistry
|
July 23, 2011
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain
Nubia Boechat, Vitor F Ferreira, Sabrina B Ferreira, et al.
BMC Health Services Research
|
April 23, 2020
Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries
H Alsdurf, O Oxlade, M Adjobimey, et al.
Molecular Oncology
|
August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities
Rui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Antimicrobial Agents and Chemotherapy
|
November 21, 2018
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
André C Ferreira, Patrícia A Reis, Caroline S de Freitas, et al.
Journal of Medicinal Chemistry
|
August 26, 2009
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity
Claudio Mapelli, Sesha I Natarajan, Jean-Philippe Meyer, et al.
Plos Neglected Tropical Diseases
|
January 31, 2019
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Caroline S de Freitas, Luiza M Higa, Carolina Q Sacramento, et al.
Scientific Reports
|
April 25, 2017
Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Carolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
Scientific Reports
|
January 19, 2017
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Carolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
The Journal of Biological Chemistry
|
August 13, 2010
Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model
Michael L Booker, Cecilia M Bastos, Martin L Kramer, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 324) with videos related to
Sort By:
Page
of 33
ESMO Open
|
November 26, 2025
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI
F Martin-Moro, L Bento, J Marquet, et al.
Journal of Medicinal Chemistry
|
July 23, 2011
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain
Nubia Boechat, Vitor F Ferreira, Sabrina B Ferreira, et al.
BMC Health Services Research
|
April 23, 2020
Resource implications of the latent tuberculosis cascade of care: a time and motion study in five countries
H Alsdurf, O Oxlade, M Adjobimey, et al.
Molecular Oncology
|
August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities
Rui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Antimicrobial Agents and Chemotherapy
|
November 21, 2018
Beyond Members of the <i>Flaviviridae</i> Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
André C Ferreira, Patrícia A Reis, Caroline S de Freitas, et al.
Journal of Medicinal Chemistry
|
August 26, 2009
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity
Claudio Mapelli, Sesha I Natarajan, Jean-Philippe Meyer, et al.
Plos Neglected Tropical Diseases
|
January 31, 2019
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
Caroline S de Freitas, Luiza M Higa, Carolina Q Sacramento, et al.
Scientific Reports
|
April 25, 2017
Corrigendum: The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Carolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
Scientific Reports
|
January 19, 2017
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Carolina Q Sacramento, Gabrielle R de Melo, Caroline S de Freitas, et al.
The Journal of Biological Chemistry
|
August 13, 2010
Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model
Michael L Booker, Cecilia M Bastos, Martin L Kramer, et al.
Page
of 33